After the unexpected death of insurance magnate J. Patrick Rooney, two organizations he led until the day he died are scrambling
to figure out who will lead them into the future.
WellPoint Inc. prides itself on working to hold down the rising cost of health care. But to hear one of its former vice
presidents tell it, the company retaliated against him when he worked to do just that. In a lawsuit against
WellPoint, Dr. Randy Axelrod claims his former employer forced him out when he tried to curtail a drugmaker’s
controversial pricing strategy that was costing WellPoint money.
Eli Lilly and Co.’s unorthodox efforts to develop new treatments for Alzheimer’s disease–if successful–could usher in
a new approach to drug development. The Indianapolis-based pharmaceutical company announced that a New York
hedge fund, TPG-Axon Capital, will invest up to $325 million to help cover the exorbitant development costs
of two experimental compounds to treat Alzheimer’s disease.
WellPoint Inc., the most dominant health insurer in the United States, registers as barely a pipsqueak in the rest of the
world. But it’s only a matter of time, say industry experts, before WellPoint plunges into foreign markets to grow sales of
its health benefits and services.
Nathan’s Battle Foundation, led by Phil Milto–who has two sons afflicted with the disease–has evolved over 10 years into
what Milto calls a not-for-profit biotech company that has raised money and guided research that resulted in a promising treatment
for Batten disease. Now, some of the gene therapy techniques researchers developed are being applied to other disorders.
Steve Smith has shaken up the Indiana Health
Care Association so much, the group representing Indiana’s for-profit nursing homes is hardly recognizable to those who knew
it before. And the way Smith tells it, he’s just getting started.
This month, 65-year-old Bill Corley gave his 18 months’ notice that he will be retiring as CEO of Community Health Network,
the third-largest hospital network based in Indianapolis. Perhaps Community’s board of directors needed so much time to replace
a man who has held his post so long-nearly 25 years. When Corley arrived in 1984, Community consisted of just one hospital
on Indianapolis’ east side. Today, it has five.
Angela Braly, Wayne DeVeydt and the rest of the top brass at WellPoint Inc. face wrath over the company’s recent stock swoon
from a new group: ex-employees. Four former WellPoint workers have filed lawsuits against the Indianapolis-based health insurance
giant over the losses its 401(k) retirement plan suffered in March when the company slashed its profit forecast for the year.
Clarian Health this decade has transformed its transplant program into one of the busiest in the country. Its team of surgeons
takes calls around the clock if a viable organ becomes available. They will hop on a charter plane to check out an organ other
doctors don’t want.
Around Indiana, hospitals continue to grow and add workers, increasing their role as an economic driver to the state’s economy.
But health care reformers say hospital growth has a double edge, as higher health care costs dampen growth prospects for other
Indiana employers and their workers.
Four years after its launch, the Indiana Health Information Exchange is laying the groundwork to take its game outside state
borders. The Indianapolis-based not-for-profit offers a service that provides patient records and test results via computer
to hospitals and doctors around central Indiana. But now, its leaders think they can take their expertise to other cities
and help them develop their own health information exchanges.
Economists call it a “virtuous cycle” when successful entrepreneurs plow their gains into new businesses. Jim Pearson calls
it another day on the job. The former Suros Surgical Systems Inc. CEO is attempting to repeat what he already has done: Build
a company to bring a promising medical device all the way from the drawing board to the market.
Service Employees International Union Local 3 is backing local janitors as they restart contract negotiations April 16 with
five of the largest janitorial contractors in Indianapolis. SEIU now is taking direct aim at Lilly, health insurer WellPoint
Inc. and even some local hospitals, hoping they will pressure the janitorial contractors to come to terms.
Anthem Insurance Co. added nearly 75,000 commercial customers last year, pushing its total up more than 4 percent. Anthem,
a subsidiary of Indianapolis-based WellPoint Inc., now claims a whopping 1.8 million commercial customers in the state. The
trouble is, Anthem’s dominance limits price competition, according to benefits brokers, making it hard for local HMOs such
as M-Plan or even some national players to compete.
The “father of health savings accounts” isn’t satisfied. At 80, J. Patrick Rooney is gearing up for another health care reform
battle in Washington–five years after winning a colossal victory when Congress awarded health savings accounts tax-free status.
Clarian Health has acquired a controlling stake in a cardiology practice based at the Indiana Heart Hospital, which is owned
by Clarian competitor Community Health Network.
Eli Lilly and Co. hopes to extend the life of its best-seller Zyprexa with a potentially lucrative, long-acting form of the antipsychotic drug. But first, the Indianapolis-based drugmaker must win over a panel of medical experts convened by the U.S. Food and Drug Administration on Feb. 6.
Three months after launching an initiative to boost drug-development firms in Indiana, officials at BioCrossroads have written
a report that attempts to show in detail the vast market opportunity they see.
At the beginning of 2007, few people outside WellPoint Inc. had even heard of Angela Braly. Nine months later, Fortune magazine
named her the fourth most powerful woman in business.
A new leader will guide the city’s largest company in 2008, with some of the biggest challenges in its history on the horizon.
Eli Lilly and Co. announced Dec. 18 that CEO Sidney Taurel will step down March 31 and will be replaced by President John
C. Lechleiter, who has been the heir apparent for more than two years.
